Pharma and Biotech
By Iain Gilbert
Date: Friday 12 Apr 2024
(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.
By Michele Maatouk
Date: Monday 27 Mar 2023
(Sharecast News) - Jounce Therapeutics said on Monday that it was ditching a planned merger with AIM-listed Redx Pharma, opting instead to be bought by Concentra Bioscences.
By Iain Gilbert
Date: Wednesday 23 Dec 2020
(Sharecast News) - Redx Pharma revealed on Wednesday that chief executive Lisa Anson had acquired 39,998 ordinary shares in the AIM-listed drug discovery and development group.
Currency | UK Pounds |
Share Price | 12.50p |
Change Today | -0.25p |
% Change | -1.96 % |
52 Week High | 36.00 |
52 Week Low | 4.25 |
Volume | 49,853 |
Shares Issued | 388.99m |
Market Cap | £48.62m |
RiskGrade | 278 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
12:13 | 1,000 @ 11.85p |
12:00 | 910 @ 11.80p |
11:47 | 7,717 @ 12.00p |
11:22 | 1,358 @ 12.00p |
11:16 | 208 @ 12.00p |
You are here: research